Analystreport

Horizon Therapeutics PLC (NASDAQ: HZNP) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating.

Horizon Therapeutics Public Limited Company - Ordinary Shares  (HZNP) 
Last horizon therapeutics public limited company - ordinary shares earnings: 2/26 07:00 am Check Earnings Report